Booster Vaccination With Pneumococcal Vaccine GSK1024850A or Prevenar™ Co-administered With Hiberix™ in Children Primed With the Same Vaccines
Phase of Trial: Phase III
Latest Information Update: 27 Sep 2018
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary) ; Hib vaccine conjugate
- Indications Influenza B virus infections; Otitis media; Pneumococcal infections
- Focus Adverse reactions; Registrational
- Sponsors GlaxoSmithKline
- 13 Jan 2012 Actual end date changed from Jan 2010 to May 2009 as reported by ClinicalTrials.gov.
- 13 Jan 2012 Actual initiation date changed from Jun 2009 to Jun 2008 as reported by ClinicalTrials.gov.
- 13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (NCT00680914).